Clinical trial
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer…
NCT00279344 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00279344 |
|---|---|
| Title | Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN) |
| Official title | A Randomised, Open, Parallel-group, Multi-centre Trial to Investigate Analgesic Efficacy and Safety of Transdermal Fentanyl (FITpatch) Compared to Standard Opioid Treatment in Cancer Pain. |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain. |
| Intervention type | Drug |
| Interventions | Fentanyl (Matrifen) |
| Enrollment | 220 |
| Start date | Sep 1, 2004 |
| Completion | Aug 1, 2007 |
| First posted | Jan 19, 2006 |
| Last update posted | May 7, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: